Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01822613
Title Study of Safety and Efficacy of the Combination of LJM716 and BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | ESP | CAN | BEL

Facility Status City State Zip Country Details
University of Chicago Medical Center Dept of Onc Chicago Illinois 60637 United States Details
Karmanos Cancer Institute Dept of Onc Detroit Michigan 48201 United States Details
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston Texas 77030-4009 United States Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Seoul Korea 03080 Korea, Republic of Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Tainan Taiwan ROC 70421 Taiwan Details
Novartis Investigative Site Taipei 10048 Taiwan Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field